|Articles|September 10, 2014
PRA Health Sciences Files for Initial Public Offering
PRA Health Sciences announced that it has filed a registration statement with the US Securities and Exchange Commission
Advertisement
PRA Health Sciences announced that it has filed a registration statement with the U.S. Securities and Exchange Commission relating to a proposed initial public offering (“IPO”) of shares of its common stock by PRA Health Sciences. The number of shares to be offered and the price range has not yet been determined.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
SCOPE Summit 2026 Panel Discussion: Diversity in Clinical Trials—What’s Working, What’s Next
2
SCOPE Summit 2026 Keynote Panel: Is Radical Acceleration in Clinical Research Possible?
3
SCOPE Summit 2026: Reducing Patient Burden Is the Foundation of Wearable Success in Oncology
4
Accelerate Clinical Trials with AI-Enhanced Financial Management
5